HCW Biologics director Scott T. Garrett acquires 7,736 common shares for $19,995.56
HCWB•Director share purchase reported
- HCW Biologics director Scott T. Garrett reported buying 7,736 common shares at $2.59 each through Garrett Capital Partners.
- The indirect stake held via the LLC rose to 41,644 shares following the purchase.
